Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05
Clinical trial NCT02255409 · COMPLETED
Trial details
- NCT number
- NCT02255409
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 607
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.